L-Methyldopa Teva (Methyldopa)

Methyldopa is a central alpha‑2 adrenergic agonist. It stimulates presynaptic alpha‑2 receptors in the brainstem, which reduces the release of norepinephrine. This decreases sympathetic outflow, leading to reduced peripheral vascular resistance and lower arterial blood pressure.

The appropriate dose of L-Methyldopa Teva is determined by the prescribing healthcare professional based on the patient’s condition, age, renal and hepatic function, and response to therapy. Dosage adjustments are made to achieve optimal blood pressure control.

Methyldopa is one of the few antihypertensives considered relatively safe in pregnancy and is often used for gestational hypertension. However, its safety during breastfeeding has not been fully established, so clinicians should weigh the benefits and risks before prescribing.

To order L-Methyldopa Teva, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and necessary import documentation.

Unlike diuretics or calcium‑channel blockers that act peripherally, methyldopa works centrally to reduce sympathetic tone. This mechanism makes it especially useful in pregnancy, where many other antihypertensives are contraindicated. Its side‑effect profile differs, with more central nervous system effects such as drowsiness.

L-Methyldopa Teva should be stored at ambient temperature, below 25 °C, in the original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing in humid or excessively hot environments.

L-Methyldopa Teva is taken orally, usually with or without food, as directed by a healthcare professional. The tablets should be swallowed whole with a glass of water and not chewed or crushed unless specifically instructed.

Serious risks include severe hypotension, liver dysfunction, hemolytic anemia, and rare but life‑threatening skin reactions such as Stevens‑Johnson syndrome. Patients should be monitored regularly for signs of these conditions, and any sudden worsening of symptoms should prompt immediate medical attention.

L-Methyldopa Teva is contraindicated in individuals with known hypersensitivity to methyldopa or any of its excipients. It should also be avoided in patients with severe liver disease, certain blood disorders, or those taking MAO inhibitors without appropriate washout periods.